BOULDER, Colo., Oct 24, 2011 (BUSINESS WIRE) --
Array BioPharma Inc. (Nasdaq:ARRY) will report financial results for the
first quarter of fiscal 2012 on Monday, October 31, 2011, and will hold
a conference call on Tuesday, November 1, 2011 at 9:00 a.m. eastern time
to discuss these results. Robert E. Conway, Chief Executive Officer, and
Michael Carruthers, Chief Financial Officer, will lead the call.
A replay of the call will be available as a webcast on www.arraybiopharma.com
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the
discovery, development and commercialization of targeted small-molecule
drugs to treat patients afflicted with cancer and inflammatory diseases.
Our proprietary drug development pipeline includes clinical candidates
that are designed to regulate therapeutically important target proteins
and are aimed at significant unmet medical needs. For more information
on Array, please go to www.arraybiopharma.com.
SOURCE: Array BioPharma Inc.
Array BioPharma Inc.
Tricia Haugeto, 303-386-1193
thaugeto@arraybiopharma.com
